MONOCARE AM TABLET

MRP

210/Strip

Description

• Each uncoated tablet contains: Levocetirizine Hydrochloride I.P. 5 mg + Montelukast sodium IP eq. to montelukast 10 mg + Ambroxol Hydrochloride IP 75 mg (as preservative release ), Excipients q.s.

Doses

• As Directed by Physician

Indication

• AMBROXOL+LEVOCETIRIZINE+MONTELUKAST combines anti-asthma and anti-allergic drugs, primarily used to prevent asthma.
• it relieves symptoms like sneezing, runny nose, and allergic skin due to various allergies.